Withdrawn before it began
Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery
NCT02370342 · University of Southern California · Updated 20 Dec 2017
- What is being tested
- Robot-Assisted Laparoscopic Surgery; High-Intensity Focused Ultrasound Ablation; Therapeutic Laparoscopic Surgery; Sonatherm 600i Ultrasonic Lesion Generating System
- For
- Renal Carcinoma; Renal Mass
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. The full rules are on the registry page.
- Where
- United States (2 sites)
- When
- Starts or started 18 Dec 2017, ends 18 Dec 2019. Registered 24 Feb 2015.
- Results
- None posted yet.
In the researchers' words
This clinical trial studies a type of ultrasound called robot-assisted laparoscopic high-intensity focused ultrasound for performing thermal ablative therapy, or sound wave therapy, in treating patients with small kidney masses undergoing partial removal of the kidney. The robot-assisted ultrasound probe takes images of the kidney to help doctors locate the mass. The probe then uses high frequency sound waves to target and ablate (or destroy) the kidney mass, which may be a cancerous tumor or benign tissue. Surgery is then performed to remove the part of the kidney with the mass. Robot-assisted laparoscopic high-intensity focused ultrasound for thermal ablative therapy may be safer and help doctors see the tumor better when performing kidney surgery.
Sites
- Keck Hospital of USCLos Angeles, California, United States
- USC Norris Comprehensive Cancer CenterLos Angeles, California, United States